Fenze 500 mg Tablet

Fenbendazole belongs to the benzimidazole class of anthelmintics, which work by binding to a structural protein in parasites called tubulin, disrupting their cellular function and ultimately preventing them from surviving and reproducing. It is widely used in veterinary medicine to treat a broad range of parasitic worm infections in animals, including dogs, cats, horses, and livestock, addressing conditions like roundworm, hookworm, whipworm, and certain tapeworm infections. It is not an approved human medication, and its safety, dosing, and effectiveness for use in people have not been established through the same rigorous clinical testing required for approved human drugs. In recent years, Fenbendazole has gained attention online in connection with unproven claims about cancer treatment in humans, largely based on anecdotal reports rather than clinical evidence; health authorities and oncologists have cautioned against these claims, noting a lack of reliable human clinical trial data to support such use, and the real risk that self-treating with unapproved substances could delay evidence-based cancer care. When used appropriately in veterinary settings, dosing is determined by a veterinarian based on the animal's species, weight, and the specific parasite being treated. Given the absence of approved human use and the potential harm of forgoing established medical treatment, Fenbendazole tablets should only be used in animals under veterinary guidance, and anyone considering it for a human health condition should speak with a licensed physician about evidence-based treatment options instead.